Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5451]
News [12658]
Articles [175]
Editorials [5]
Conferences [249]
elearning [17]
A 'recovery care package' post-treatment in Africa
Prof Theresa Wiseman - Royal Marsden Hospital, London, UK
A 'recovery care package' post-treatment in Africa ( Prof Theresa Wiseman - Royal Marsden Hospital, London, UK )
28 Feb 2020
Uganda as a case study for cancer care initiatives in Africa
Dr Warren Phipps - Fred Hutchinson Cancer Research Center, Seattle, USA
Uganda as a case study for cancer care initiatives in Africa ( Dr Warren Phipps - Fred Hutchinson Cancer Research Center, Seattle, USA )
28 Feb 2020
Investigating fear of recurrence in breast cancer patients
Prof Gerry Humphris - University of St Andrews, St Andrews, UK
Investigating fear of recurrence in breast cancer patients ( Prof Gerry Humphris - University of St Andrews, St Andrews, UK )
25 Feb 2020
Shorter hormone therapy for prostate cancer
Dr André-Guy Martin - Centre Hospitalier Universitaire de Québec, Québec City...
Shorter hormone therapy for prostate cancer ( Dr André-Guy Martin - Centre Hospitalier Universitaire de Québec, Québec City, Canada )
24 Feb 2020
Treatment of early stage adenocarcinoma
Dr C S Pramesh - Tata Memorial Hospital, Mumbai, India
Treatment of early stage adenocarcinoma ( Dr C S Pramesh - Tata Memorial Hospital, Mumbai, India )
20 Feb 2020
Treatment of early stage cervical and ovarian cancer
Dr Rama Joshi - Foirtis Memorial Research Institute, Gurgaon, India
Treatment of early stage cervical and ovarian cancer ( Dr Rama Joshi - Foirtis Memorial Research Institute, Gurgaon, India )
20 Feb 2020
EV-103: Enfortumab vedotin plus pembrolizumab for locally advanced or...
Dr Jonathan Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA
EV-103: Enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma ( Dr Jonathan Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA )
19 Feb 2020
KEYNOTE 199 cohorts 4 & 5: Enzalutamide and pembrolizumab for mCRPC
Dr Julie Graff - Oregon Health & Science University, Portland, USA
KEYNOTE 199 cohorts 4 & 5: Enzalutamide and pembrolizumab for mCRPC ( Dr Julie Graff - Oregon Health & Science University, Portland, USA )
19 Feb 2020
BCG dosing for bladder cancer: Standard frequency schedule correct
Prof Oliver Grimm - Universitätsklinikum Jena, Jena, Germany
BCG dosing for bladder cancer: Standard frequency schedule correct ( Prof Oliver Grimm - Universitätsklinikum Jena, Jena, Germany )
19 Feb 2020
RADVAX: Nivolumab / ipilimumab with SBRT for metastatic renal cell carcinoma
Dr Hans Hammers - UT Southwestern Medical Center, Dallas, USA
RADVAX: Nivolumab / ipilimumab with SBRT for metastatic renal cell carcinoma ( Dr Hans Hammers - UT Southwestern Medical Center, Dallas, USA )
19 Feb 2020
CHAARTED: Luminal B subtype as a biomarker of docetaxel benefit for mHSPC
Dr Anis Hamid - Dana-Farber Cancer Institute, Boston, USA
CHAARTED: Luminal B subtype as a biomarker of docetaxel benefit for mHSPC ( Dr Anis Hamid - Dana-Farber Cancer Institute, Boston, USA )
19 Feb 2020
Integrative molecular characterisation of S/R RCC to reveal determinants of...
Dr Ziad Bakouny - Dana-Farber Cancer Institute, Boston, USA
Integrative molecular characterisation of S/R RCC to reveal determinants of poor prognosis and response to ICIs ( Dr Ziad Bakouny - Dana-Farber Cancer Institute, Boston, USA )
18 Feb 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation